-
Lanabecestat: Practical BACE1 Assay Workflows
2026-09-21
Lanabecestat (AZD3293) combines nanomolar BACE1 potency with blood-brain barrier penetration, making it useful for connecting amyloid-beta production inhibition to neuronal-function assays. This guide translates published synaptic-safety findings into practical workflows, exposure controls, and troubleshooting decisions for Alzheimer’s disease research.
-
EZ Cap™ Human PTEN mRNA: Assay Design
2026-09-21
Explore how EZ Cap™ Human PTEN mRNA can anchor mechanism-driven cancer research, from PI3K/Akt pathway restoration to delivery-aware assay design. This article translates recent HA-LNP findings into practical decisions for interpreting PTEN expression and function.
-
mCherry mRNA for LNP Delivery Assay Design
2026-09-20
Use a Cap 1, modified-nucleotide mCherry reporter to separate delivery, translation, and cell-health effects in demanding in vitro workflows. This guide translates the COL7A1 base-editing study into practical LNP benchmarking, reporter assays, and troubleshooting decisions without confusing fluorescence with editing efficacy.
-
EZ Cap™ Mouse IL-7 mRNA: Assay Design Guide
2026-09-19
EZ Cap™ Mouse IL-7 mRNA (m1Ψ, HA tag) enables a controlled, traceable IL-7 expression workflow for mechanistic assays. This guide connects its use to APOL1 isoform, haplotype, and protein-interaction questions while clearly separating established evidence from exploratory applications.
-
Isradipine (Dynacirc) Research Workflows
2026-09-19
Isradipine (Dynacirc) provides a practical way to interrogate L-type calcium influx across neuronal, vascular, and hypertension research workflows. This guide connects formulation, calcium-response assays, electrophysiology, and troubleshooting while using channel-selectivity evidence to avoid overinterpreting neuroprotective results.
-
Silybin A: Silymarin Research Reference
2026-09-18
Silybin A is a defined flavonolignan associated with Silymarin and supplied for antioxidant, inflammatory, metabolic, and liver-biology research. Its documented DMSO solubility and storage requirements support controlled in-vitro workflows, while evidence from a praeruptorin A hepatocellular-carcinoma study must not be treated as direct evidence for Silybin A.
-
Beijing M. pneumoniae Resistance in 2023
2026-09-18
A 2024 Beijing study found universal erythromycin and azithromycin resistance among 62 pediatric Mycoplasma pneumoniae isolates, alongside higher azithromycin MICs in 2023 and a uniform A2063G mutation. Its comparison of 16-membered macrolide acetylspiramycin with standard macrolides provides a useful framework for antimicrobial resistance research, while the clinical and molecular data clarify the limits of MIC-based interpretation.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-09-17
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide solubilizer for poorly water-soluble compounds, particularly molecules with aromatic or phenyl-containing regions. This dossier-based guide supports pharmaceutical and biochemical formulation workflows, but does not establish therapeutic, in vivo, clinical, or bioavailability outcomes.
-
EdU Imaging Kits (488) for NSCLC Cell-Cycle Studies
2026-09-17
EdU Imaging Kits (488) turn S-phase labeling into an imageable, flow-compatible readout for testing proliferation changes in NSCLC models. The workflow is especially useful when researchers need to connect treatment-induced growth suppression with cell-cycle arrest while preserving morphology and antigen-binding sites.
-
Roscovitine Workflows for CDK Cell-Cycle Studies
2026-09-16
Roscovitine (Seliclib, CYC202) enables reversible interrogation of CDK-driven cell-cycle transitions, from biochemical kinase assays to cellular phenotyping and tumor-model planning. This guide combines practical dosing, washout, assay controls, and cheminformatics-informed compound selection to improve interpretability in cancer biology research.
-
EGFP mRNA m1Ψ: From Signal to Insight
2026-09-15
A mechanistic and translational framework for using Cap 1 EGFP mRNA containing N1-methylpseudouridine to separate delivery, translation, and protein-expression biology in reporter studies.
-
Cholesterol: Building Causal mRNA-LNP Assays
2026-09-15
Cholesterol is the principal sterol in membrane and lipid nanoparticle research, but its effects are often confounded by formulation variables. This guide presents an evidence-aware assay framework that connects cholesterol chemistry with the localized p21 mRNA-LNP findings in bladder cancer.
-
Angiotensin 1/2 (5-7) Workflow Guide
2026-09-14
Build reproducible cardiovascular, receptor-binding, and exploratory viral-interface assays with a defined H2N-Ile-His-Pro-OH peptide. This guide combines practical preparation, concentration scouting, controls, and troubleshooting while separating established findings from recommended workflow conditions.
-
Perifosine as an Akt Pathway Stress-Test
2026-09-14
Perifosine (KRX-0401) can serve as more than an oncology reagent: it is a chemical stress-test for linking Akt/mTOR signaling to apoptosis, Golgi stress, and treatment response. This article translates evidence from cancer models and cerebral ischemia/reperfusion research into a rigorous assay-design strategy.
-
Morning Training Improves Endurance Adaptation in Mice
2026-09-13
Hesketh et al. show that early-active-phase endurance training produces a faster improvement in treadmill performance than late-active-phase training in female mice, even when the early-training group completes less absolute work. The findings position exercise timing as an important experimental variable and connect performance adaptation with skeletal-muscle mitochondrial and contractile remodeling rather than with differences in terminal glycogen stores.